Related Experiment Video
Updated: Jul 28, 2026
10:19
A Murine Model of Group B Streptococcus Vaginal Colonization
Published on: November 16, 2016
Group B streptococcal infection in the newborn
Critical Care Nursing Clinics of North America
|September 1, 1992
Summary
Group B Streptococcus (GBS) is a bacterium that can be acquired during childbirth. This review covers GBS characteristics, transmission, symptoms, and treatments, including immunoglobulin therapy.
Area of Science:
- Immunology
- Microbiology
- Neonatal Health
Background:
- Group B Streptococcus (GBS) is a significant cause of neonatal infections.
- Understanding GBS pathogenesis is crucial for effective prevention and treatment strategies.
Purpose of the Study:
- To provide a comprehensive review of Group B Streptococcus.
- To discuss immunologic and microbiologic aspects, perinatal acquisition, clinical manifestations, and therapeutic options for GBS infections.
Main Methods:
- Literature review of immunologic and microbiologic characteristics.
- Analysis of perinatal acquisition pathways.
- Review of clinical presentations and current therapeutic approaches.
- Inclusion of a case study for practical illustration.
Main Results:
- Detailed examination of GBS virulence factors and host immune responses.
- Identification of key routes for perinatal transmission.
- Synopsis of common and severe clinical presentations of GBS disease.
- Evaluation of antibiotic therapy and immunoglobulin transfusion efficacy.
Conclusions:
- Effective management of GBS requires a thorough understanding of its biology and transmission.
- Immunoglobulin therapy may offer an adjunctive treatment option.
- Further research into GBS prevention and novel therapies is warranted.
Related Concept Videos
01:22Development of Immunocompetence
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
01:28Development of the Oral Microbiota
The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
01:24Bacterial Meningitis
Bacterial meningitis is a severe infectious disease involving inflammation of the meninges, the protective membranes surrounding the brain and spinal cord. It occurs when pathogenic bacteria cross the blood–brain barrier and enter the cerebrospinal fluid. Common causative organisms include Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae type b, Listeria monocytogenes, and Escherichia coli K1. The exact route of entry varies by pathogen and host condition.Routes of Entry...
01:27Streptococcal Pharyngitis
Streptococcal pharyngitis, commonly known as “strep throat,” is an acute infection of the oropharyngeal tissues caused by the Gram‑positive Group A Streptococcus (Streptococcus pyogenes). Transmission occurs primarily through respiratory droplets expelled during coughing, sneezing, or talking.Mechanisms of Host Entry and Immune EvasionUpon entering the host, S. pyogenes adheres to the mucosal epithelial cells of the pharynx via surface proteins, notably lipoteichoic acid and the antiphagocytic...
01:22Bacterial Meningitis I: Introduction
Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
01:26Bacterial Meningitis II: Pathophysiology
Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...